Mary Mader

Expert Scientific Advisory Committee, Chair @Medicines for Malaria Venture

Indianapolis, IN, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2023 — Present

Expert Scientific Advisory Committee, Chair @Medicines for Malaria Venture

View department →

Geneva, CH

Provide medicinal chemistry expertise in the review of lead generation and lead optimization collaborations supported by MMV.

EDUCATION

1981 — 1985

The Ohio State University

BS, Chemistry

1986 — 1990

University of Notre Dame

PhD, organic chemistry

1991 — 1993

University of California, Berkeley

Post-Doc., bioorganic chemistry

SKILLS

CheminformaticsDrug DiscoveryOrganic SynthesisMedicinal ChemistryDrug DevelopmentOrganic ChemistryDrug DesignOncologyHplcLife SciencesPharmaceutical IndustryBiotechnologyChemistry

ABOUT MARY MADER

Experienced medicinal chemist with focus on oncology and neuroscience drug discovery from Lead generation through Lead Optimization resulting in identification of multiple Development Candidates and IND submissions. Familiar target classes include kinases, methyltransferases and bromodomains, modulated through varied mechanisms (orthosteric, allosteric, covalent). Passionate advocate for the use of in silico methods applied to drug discovery and drug design through strong partnerships with computational scientists, structural biologists and DMPK scientists.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mary Mader — Expert Scientific Advisory Committee, Chair at Medicines for Malaria Venture in Indianapolis, IN, US | Unifers